Investor Announcements - 2012

Interim results

24^th Sep 2012

EKF announces 2012 Interim Results.

HemoCue settlement agreement

10^th Aug 2012

EKF Diagnostics announces that subsidiaries of EKF have entered into a Settlement Agreement with HemoCue AB and HemoCue Inc in relation to patent-related litigation in Germany and the US.

Licensing Agreement for Kidney Markers

17^th Jul 2012

EKF Diagnostics announces that it has signed an exclusive license agreement with the Joslin Diabetes Center (“Joslin”).

Disposal of International Brand Licensing AG

27^th Mar 2012

EKF Diagnostics announces that it has sold its Swiss subsidiary, International Brand Licensing AG for a cash consideration of £50,000, payable over a two year period.

Final results for the year ended 31 December 2011

21^st Mar 2012

EKF Diagnostics announces its audited final results for the year ended 31 December 2011, a year of continued progress.

Archive

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

Reliable Point-of-Care lactate analysis in cattle

Measuring lactate concentrations in cattle has been shown to be incredibly useful. This article discusses new methods available to farmers and veterinarians to get fast and reliable results without leaving the animal’s side.

EKF at Algeria Health - December 2018

Visit EKF Diagnostics at the largest healthcare event in the MAGHREB region. Algeria Health will be held on 5-8 December 2018 at the Palais des Expositions, Algiers.

EKF launches pocket-sized lactate monitor for sports performance monitoring at MEDICA 2018

EKF Diagnostics will be launching its new Lactate Scout 4 hand-held lactate analyzer for fast and accurate sports performance monitoring. Lactate Scout 4 is designed for use in the field as a training companion for individuals or sports teams, and will be demonstrated to delegates attending the co-located MEDICA MEDICINE + SPORTS conference.

EKF at MEDICA - November 2018

MEDICA is the world’s largest medical trade fair. For more than 40 years it has been firmly established on every expert’s calendar attracting over 40,000 delegates and over 5,000 exhibitors from 70 countries in 17 halls.

HbA1c testing at the point-of-care: Comparison against international quality standards